Skip to search.
 TSX Up 0.85% TSX Ventures  0.00%
Streaming
Ticker Tape: On

Biogen Idec Inc. (BIIB)

-NasdaqGS
291.67 Up 6.18(2.16%) 12:14PM EDT - Nasdaq Real Time Price
Add to Portfolio
Prev Close:285.49
Open:290.28
Bid:292.51 x 100
Ask:292.99 x 200
1y Target Est:346.84
Beta:1.34
Next Earnings Date:23-Apr-14BIIB Earnings announcement
Day's Range:284.17 - 294.00
52wk Range:194.66 - 358.89
Volume:742,080
Avg Vol (3m):1,783,350
Market Cap:68.95B
P/E (ttm):37.35
EPS (ttm):7.81
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):20.88
P/S (ttm):9.74
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :11.31
Quarterly EPS Est (Mar-14) :2.57
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):1.35

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Biogen Idec Inc. discovers, develops, manufactures, and markets therapies for the treatment of neurodegenerative diseases, hemophilia, and autoimmune disorders in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback